tirzepatide compared to mounjaro (Tirzepatide) vs Semaglutide Mounjaro (tirzepatide): Dual-Action Diabetes and

Like many emerging therapies, BPC-157 exists in an area where scientific interest has moved faster than the clinical evidence

Some experts have warned, though, that the drug is not a replacement for eating well and exercising and should only be given under medical supervision

The study found that patients on GLP-1 agonists experienced a 35% reduction in myocardial infarctions compared to the matched control group, along with a 22% reduction in ischemic strokes and an 18% reduction in heart failure exacerbations

Semaglutide was developed as an antidiabetic medication, but you dont need to have type 2 diabetes to experience the benefits